Top Markets
Coin of the day
Antibe Therapeutics Inc. Antibe Therapeutics Inc.

Antibe Therapeutics Inc.

ATE
Ранг среди акций #32096
Antibe Therapeutics Inc. is a biotechnology company specializing in the... Antibe Therapeutics Inc. is a biotechnology company specializing in the development of groundbreaking therapeutics and medical devices. Operating internationally, including Canada, Europe, and the United States, their work targets pain, inflammation, and regenerative medicine. A key focus is developing drugs designed to prevent the gastrointestinal harm and bleeding often caused by non-steroidal anti-inflammatory drugs. Their leading candidate, Otenaproxesul, is a hydrogen sulfide-releasing derivative of naproxen. This compound has already finished a Phase 2B gastrointestinal safety study and is being investigated for a range of indications, such as post-operative pain, migraines, dysmenorrhea, traumatic injuries, dental pain, and gout. Additionally, their product portfolio features ATB-352, currently in preclinical development for managing acute pain. The company, incorporated in 2009, is headquartered in Toronto, Canada.
Цена акции
$0.21483059
Последняя синхронизация: 2024-05-07
Рыночная капитализация
$11.13M
Изменение (1 день)
0.34%
Изменение (1 год)
0.00%
Страна
CA
Торговля Antibe Therapeutics Inc. (ATE)

Категория

Коэффициент P/S для Antibe Therapeutics Inc. (ATE)
Коэффициент P/S на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Antibe Therapeutics Inc., текущий коэффициент P/S (TTM) составляет 0. В конце 2026 он составлял 0.
История P/S для Antibe Therapeutics Inc. с 2026 по 2026
Коэффициент P/S в конце каждого года
Год P/S Изменить
Недостаточно данных для указанных дат.
Коэффициент P/S для аналогичных компаний или конкурентов
Компания P/S Разница P/S Страна
4.13 -
US
5.03 -
US
2.78 -
IE
3.67 -
US
8.10 -
US